An integrative approach using real-world data to identify alternative therapeutic uses of existing drugs

scientific article published in PLoS ONE

An integrative approach using real-world data to identify alternative therapeutic uses of existing drugs is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PONE.0204648
P932PMC publication ID6177143
P698PubMed publication ID30300381

P50authorKouichi HosomiQ92147598
Kazutaka UshioQ92147600
P2093author name stringLili Mao
Mitsutaka Takada
Mai Fujimoto
Juran Kato
P2860cites work15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.Q35698498
Opportunities for Web-based Drug Repositioning: Searching for Potential Antihypertensive Agents with Hypotension Adverse EventsQ36804419
Novel statistical tools for monitoring the safety of marketed drugsQ36835511
In silico methods for drug repurposing and pharmacologyQ36837816
Treatment of diarrhea in patients with inflammatory bowel disease: concepts and cautions.Q37056204
Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage.Q37511294
Systems pharmacology of adverse event mitigation by drug combinationsQ37658567
Cytokines in inflammatory bowel diseaseQ39206254
Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims DatabaseQ40075147
Lipopolysaccharide induces CXCL2/macrophage inflammatory protein-2 gene expression in enterocytes via NF-kappaB activation: independence from endogenous TNF-alpha and platelet-activating factorQ40268445
Integrative transcriptomic meta-analysis of Parkinson's disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson's diseaseQ41215282
The emergence of genome-based drug repositioningQ42080559
Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysisQ46072124
Treatment of ulcerative colitis with thioproperazine.Q48894542
Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and ratesQ24647071
Connections in pharmacology: innovation serving translational medicineQ27008514
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsQ27861111
Navigating chemical space for biology and medicineQ28298611
Systematic drug repositioning based on clinical side-effectsQ28478506
The Connectivity Map: a new tool for biomedical researchQ28530408
OpenVigil FDA - Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical ApplicationsQ28551997
A survey of current trends in computational drug repositioningQ28602324
Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public DataQ28749098
The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and diseaseQ29547614
Drug repositioning: identifying and developing new uses for existing drugsQ29614779
Computational and experimental advances in drug repositioning for accelerated therapeutic stratificationQ30487562
Computational drug repositioning: from data to therapeuticsQ30594820
Data mining of the public version of the FDA Adverse Event Reporting SystemQ30651235
Association of statin use with sleep disturbances: data mining of a spontaneous reporting database and a prescription databaseQ30803396
Inverse Association between Sodium Channel-Blocking Antiepileptic Drug Use and Cancer: Data Mining of Spontaneous Reporting and Claims DatabasesQ31040399
Prevention of antipsychotic-induced hyperglycaemia by vitamin D: a data mining prediction followed by experimental exploration of the molecular mechanismQ31097538
Association between Benzodiazepine Use and Dementia: Data Mining of Different Medical DatabasesQ31144205
Discovery and preclinical validation of drug indications using compendia of public gene expression dataQ33995422
Diagnosing the decline in pharmaceutical R&D efficiencyQ34257771
The many roles of computation in drug discoveryQ34307063
Applications of Connectivity Map in drug discovery and developmentQ34378751
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.Q34629802
Association between statin use and cancer: data mining of a spontaneous reporting database and a claims databaseQ35069176
Exploiting drug-disease relationships for computational drug repositioningQ35109885
NF-κB in the regulation of epithelial homeostasis and inflammationQ35347805
A Bayesian neural network method for adverse drug reaction signal generation.Q52238255
Changing Trends in Computational Drug Repositioning.Q55717464
The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detectionQ57305014
Can you teach old drugs new tricks?Q59080940
The waiting time distribution as a graphical approach to epidemiologic measures of drug utilizationQ61964816
Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysisQ71666481
Animal models of inflammatory bowel diseaseQ82786536
Parthenolide, an inhibitor of the nuclear factor-κB pathway, ameliorates dextran sulfate sodium-induced colitis in miceQ82881419
A review of connectivity map and computational approaches in pharmacogenomicsQ87648094
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue10
P407language of work or nameEnglishQ1860
P304page(s)e0204648
P577publication date2018-10-09
P1433published inPLOS OneQ564954
P1476titleAn integrative approach using real-world data to identify alternative therapeutic uses of existing drugs
P478volume13